Global perspectives - Preliminary injunctions in life sciences

45 minute read
24 February 2021

What happens when a generic or biosimilar enters a market where patents are in force? What preliminary measures exist?

On February 23, our professionals from the UK, Canada, China and France hosted a live webinar exploring global perspectives on the use of preliminary injunctions (PIs) in the life sciences sector. Over the course of the event, our team will answer a range of important questions, including:

  • How common are PIs across various jurisdictions?
  • When might a PI be sought – upon launch or marketing approval?
  • What is the procedure for seeking a PI?
  • What are the unique considerations for life sciences companies?

Download the presentation

*This program is eligible for up to 1 hour of substantive CPD credits with the LSO and LSBC, and may be eligible for up to 1 hour of CPD/CLE credits in other jurisdictions.

NOT LEGAL ADVICE. Information made available on this website in any form is for information purposes only. It is not, and should not be taken as, legal advice. You should not rely on, or take or fail to take any action based upon this information. Never disregard professional legal advice or delay in seeking legal advice because of something you have read on this website. Gowling WLG professionals will be pleased to discuss resolutions to specific legal concerns you may have.